Although these studies suggested that CD47 was overexpressed in breast cancer and associated with the development or prognosis of breast cancer, most studies are based on the detection of CD47 expression at the cytological level, there is little direct evidence to report the expression of CD47 in breast cancer solid tumors and its relationship with prognosis. The gene discussed is CD47; the disease is breast carcinoma.